SCHEMBL9330265

SCHEMBL9330265

CCOC(=O)CNC(=O)/C=C/S(=O)(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPID Q08752 2/20 0.52
ALDH1A1 P00352 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
HTT P42858 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.47
XBP1 P17861 1/20 0.47
MAPK1 P28482 1/20 0.47
AGTR1 P30556 1/20 0.47
KDM4E B2RXH2 3/20 0.46
HSD11B1 P28845 1/20 0.45
CNR2 P34972 2/20 0.43
MMP2 P08253 1/20 0.43
PKM P14618 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ATM Q13315 1/20 0.42
POLB P06746 1/20 0.41
PPIB P23284 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9330271 1.00 PPID (0.52) PPIDALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL9333566 0.79 ALDH1A1 (0.43) PPIDALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL19209521 0.79 MAPT (0.66) ALDH1A1NPSR1HTTSMN1; SMN2LMNA
SCHEMBL9542426 0.79 MAPT (0.66) ALDH1A1NPSR1HTTSMN1; SMN2LMNA
SCHEMBL13901447 0.76 PPID (0.55) PPIDALDH1A1HTTSMN1; SMN2LMNA
SCHEMBL3899535 0.74 HSD11B1 (0.61) PPIDALDH1A1HSD11B1MMP2POLB
SCHEMBL10908450 0.72 PPID (0.57) PPIDALDH1A1HTTSMN1; SMN2LMNA
SCHEMBL20733397 0.70 ALDH1A1 (0.65) ALDH1A1NPSR1HTTSMN1; SMN2LMNA
SCHEMBL9845673 0.70 ALDH1A1 (0.65) ALDH1A1NPSR1HTTSMN1; SMN2LMNA
SCHEMBL28980625 0.70 ALDH1A1 (0.65) ALDH1A1NPSR1HTTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5214045-A Acrylamides having amide substituted by residues of glycine, alanine, aspartic acid, methionine, proline or thiazolidinecarboxylic acid and acrylic group substituted by phenylthio-, phenylsulfinyl- or phenylsulfonyl-groups RICHTER GEDEON VEGYESZETI GYAR RT (HU) 1993-05-25 US claimed
EP-0408106-B1 Novel acrylic amide derivatives, a process for their preparation, pharmaceutical compositions containing the same and their use in medicine RICHTER GEDEON VEGYESZET (HU) 1994-04-06 EP disclosed
US-5214045-A Acrylamides having amide substituted by residues of glycine, alanine, aspartic acid, methionine, proline or thiazolidinecarboxylic acid and acrylic group substituted by phenylthio-, phenylsulfinyl- or phenylsulfonyl-groups RICHTER GEDEON VEGYESZETI GYAR RT (HU) 1993-05-25 US disclosed
EP-0408106-A2 Novel acrylic amide derivatives, a process for their preparation, pharmaceutical compositions containing the same and their use in medicine RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1991-01-16 EP disclosed